ENTRY       D09537                      Drug
NAME        Favipiravir (JAN/USAN/INN);
            Avigan (TN)
  ABBR      FPV
FORMULA     C5H4FN3O2
EXACT_MASS  157.0288
MOL_WEIGHT  157.1026
CLASS       Antiviral
             DG03029  Anti-influenza virus agent
            Metabolizing enzyme substrate
             DG02953  AOX1 substrate
             DG02975  XDH substrate
            Metabolizing enzyme inhibitor
             DG01641  CYP2C8 inhibitor
             DG02952  AOX1 inhibitor
REMARK      Therapeutic category: 6250
            ATC code: J05AX27
            Product: D09537<JP>
EFFICACY    Antiviral, RNA polymerase inhibitor
COMMENT     Treatment of viral infection (broad-spectrum of anti-RNA virus activities)
TARGET      Influenza A virus RNA-directed RNA polymerase [KO:K19389]
  PATHWAY   ko03230(K19389)  Viral genome structure
            ko03240(K19389)  Viral replication
            ko05164(K19389)  Influenza A
METABOLISM  Enzyme: AOX1 [HSA:316]; XDH [HSA:7498]
INTERACTION CYP inhibition: CYP2C8 [HSA:1558]
            Enzyme inhibition: AOX1 [HSA:316]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AX Other antivirals
                 J05AX27 Favipiravir
                  D09537  Favipiravir (JAN/USAN/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D09537  Favipiravir (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG03029  Anti-influenza virus agent
               D09537  Favipiravir
             Metabolizing enzyme substrate
              DG02953  AOX1 substrate
               D09537  Favipiravir
              DG02975  XDH substrate
               D09537  Favipiravir
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               D09537  Favipiravir
              DG02952  AOX1 inhibitor
               D09537  Favipiravir
            Drug classes [BR:br08332]
             Antiviral
              DG03029  Anti-influenza virus agent
               D09537  Favipiravir
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               Other inhibitor
                D09537  Favipiravir (JAN/USAN/INN) &lt;JP&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               Other inhibitor
                D09537  Favipiravir (JAN/USAN/INN)
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09537
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09537
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09537
DBLINKS     CAS: 259793-96-9
            PubChem: 96026217
            ChEBI: 134722
            LigandBox: D09537
ATOM        11
            1   C8x C    17.8500  -21.4200
            2   C8y C    17.8500  -20.0200
            3   N5x N    19.0400  -19.3200
            4   C8y C    20.3000  -20.0200
            5   C8y C    20.3000  -21.4200
            6   N5x N    19.0400  -22.1200
            7   X   F    16.6600  -19.3200
            8   O1a O    21.4900  -22.1200
            9   C5a C    21.4900  -19.3200
            10  N1a N    22.6800  -20.0200
            11  O5a O    21.4900  -17.9200
BOND        11
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     2   7 1
            8     5   8 1
            9     4   9 1
            10    9  10 1
            11    9  11 2
///
